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Background/aim: The aim of this study is to determine the reference ranges of 25-hydroxyvitamin D3 (25(OH)vitD3) by an indirect
method using data obtained from patients over the course of 3 years.
Materials and methods: The 25(OH)vitD3 test results of the patients who applied to the medical biochemistry laboratory of Balıkesir
State Hospital between the years of 2010 and 2014 were analyzed. Patient data were retrospectively taken from the laboratory information
system. The 25(OH)vitD3 levels of patients were examined after exclusion of outliers. Patients were divided into subgroups according to
season, sex, and age. The central 95% reference intervals were calculated using a nonparametric method.
Results: Calculated reference intervals showed lower values than the recommended reference values of the manufacturer. In our study,
25(OH)vitD3 test results obtained for the reference values were 6.43–30.0 ng/mL for the percentile range of 2.5–97.5. For 25(OH)vitD3,
the determined reference interval for our data was significantly different from the data provided by the manufacturer.
Conclusion: This work should also be carried out in a healthy population. Data obtained from this study can be combined with the
reference range determination studies for other regions in Turkey, and therefore it can contribute to the determination of the reference
ranges of the Turkish community. This study is important for verification of the reference range recommended by the manufacturer.
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1. Introduction
A reference interval is defined as the interval that
determines the reference values for clinical diagnostic
laboratory tests, provided from the sample reference
distribution of the values obtained from a well-defined
healthy population using certain statistical methods
(1). The International Federation of Clinical Chemistry
(IFCC) and Clinical and Laboratory Standards Institute
(CLSI) both advise that each laboratory should determine
its own reference intervals (2,3). Due to regional and
laboratory differences based on population, diet, technical
equipment used, and selection of the reference group, it is
extremely important for each laboratory to determine its
own reference intervals (4).
The calculation of a reference interval and especially
the determination of the estimation limits is a matter of
debate. Increases in the variety of analysis techniques and
methods, due to improvements in technology, have led to
the necessity of practical and reliable calculation methods.
The most widely used methods considered by clinical
laboratories in calculating reference intervals are those
* Correspondence: bitigic@hotmail.com
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proposed by the CLSI (nonparametric) and the IFCC
(parametric and nonparametric) (2,5,6).
In determining the reference interval, direct and
indirect methods are used to select the reference subjects
that are most representative of the population. The
direct method is the selection of the subjects from the
main population based on predefined criteria, in which
questionnaires prepared based on these criteria are first
completed and then laboratory analyses of the subjects are
performed (2,5). The indirect method is the selection of
test results according to certain rules from a database in
which the analysis of the results are recorded regardless of
individuals (7).
Vitamin D has two forms: cholecalciferol (vitamin D3)
and ergocalciferol (vitamin D2). The efficacy of vitamin
D2 is less than one-third that of vitamin D3. The main
supply of vitamin D3 comes from 7-dehydrocholesterol. It
is converted to cholecalciferol in the skin with the effect
of UV light. Vitamin D3 forms 25-hydroxycholecalciferol
(25(OH)vitD3) in the liver with the effect of 25-hydroxylase.
25(OH)vitD3 is converted to 1,25-dihydroxyvitamin D3 in
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the kidneys with the effect of 1-alpha-hydroxylase, which
is the biologically active form. Vitamin D exists in the
circulation primarily as 25(OH)vitD3 (8).
Large-scale studies have proven that vitamin D
deficiency may be a risk factor for many public health
disorders. Vitamin D deficiency increases the risk of
various types of cancer, cardiovascular diseases, diabetes,
autoimmune and metabolic disorders, infectious
diseases arising from immune deficiency, and even some
neuropsychiatric disorders (9–14). It is therefore important
to determine the vitamin D levels of the population.
The present study aimed to evaluate the vitamin D
levels of the population of the province of Balıkesir and
to determine the population-based reference values of the
25(OH)vitD3 test using the indirect method.
2. Materials and methods
The study included the results of 25(OH)vitD3 tests
performed between 2010 and 2014 in the clinical
biochemistry laboratory at Balıkesir State Hospital.
Permission to use the data was granted by the Balıkesir
General Secretary of the Union of Public Hospitals
(approval number and date: 3178 and 26/02/2014). The
results were obtained retrospectively from the laboratory
information system. Female (n = 6739) and male (n =
1225) patients between 18 and 70 years old were initially
selected. Extreme values were excluded by using SPSS 16.0,
and the results of 5853 (84.1%) female and 1104 (15.9%)
male patients were then evaluated. The mean ages of female
and male patients were 46 and 48 years, respectively. In
consideration of age, the patient group was separated into
five subgroups (18–30 years, 31–40 years, 41–50 years,
51–60 years, and 61–70 years). Patients were also grouped
according to the seasons: winter (December-JanuaryFebruary), spring (March-April-May), summer (JuneJuly-August), and fall (September-October-November).
Patient results from nephrology and oncology
clinics were not included in the study. Results from
other clinics of patients with vitamin D deficiency and
hyperparathyroidism were also eliminated. In order to
avoid patient repetition and involvement of patients taking
vitamin D, only the initial vitamin D values of the subjects
were included. 25(OH)vitD3 test results showing the upper
and lower limits of the reference range (4–100 ng/mL)
were also not included.
Serum
25(OH)vitD3
measurements
were
performed on a Cobas E411 instrument using the
electrochemiluminescence immunoassay method (Roche
Diagnostics GmbH, Mannheim, Germany). Control
material PreciControl Bone (Level 1-2-3) was used for
internal quality control. Intraassay precision values of the
test for the concentrations of 22.7, 44.9, and 74.2 ng/mL
were 4.8%, 4.0%, and 4.1%, respectively, while interassay

precision values for the same concentrations were 8.6%,
7.7%, and 6.6%, respectively.
2.1. Statistical methods and calculations
The nonparametric method was used to calculate the
reference interval. Extreme values were excluded using
SPSS 16.0. Upper and lower limit values of the reference
interval were calculated using the nonparametric method
(percentile estimation method), and points corresponding
to 95% of the distribution were sought. Related formulas
are given below:
Lower limit value = 0.025 × (n + 1),
Upper limit value = 0.975 × (n + 1),
‘n’ = the number of data [2].
Results were evaluated using SPSS 16.0. The
Kolmogorov–Smirnov Z-test was used as a normal
distribution test. The Mann–Whitney U-test was used
for comparisons between two groups, while a one-way
variance analysis was applied for comparisons of age
subgroups and season groups. For multiple comparisons
of groups that showed differences in variance analysis, the
Tukey test was used for groups that showed homogeneous
variance, and the Tamhane test was used for groups
that did not show homogeneous variance. P < 0.05 was
accepted as statistically significant.
3. Results
Statistics of all patients’ data before and after the elimination
of extreme values, including their descriptive statistical
data, are presented in Table 1. Descriptive statistical data
for sex and age groups after the elimination of extreme
values are presented in Table 2, and for season groups they
are given in Table 3.
The reference interval calculated for 25(OH)vitD3
levels was notably lower than those proposed by the
producing company (health-based reference values were
20–32 ng/mL and population-based reference values
were 24–60 ng/mL) (Table 4). In the current study, a
95% reference interval for 25(OH)vitD3 calculated using
the indirect method was 6.43–30.0 ng/mL. Comparison
between the sexes showed a significant difference (P <
0.05). The reference intervals calculated for the female
and male patients were 6.3–29.05 ng/mL and 8.65–
34.86 ng/mL, respectively. Age groups did not show
statistically significant differences (P > 0.05, Table 2).
However, differences were significant between the season
groups. Patients in the summer group showed significant
differences when compared to the patients in the other
season groups. The highest mean 25(OH)vitD3 levels
were detected in summer and fall, whereas the lowest
mean levels were detected in winter and spring (Table 3).
When the cut-off value for 25(OH)vitD3 deficiency
was accepted to be <20 ng/mL, we determined vitamin
D deficiency in 71.23% (4956 patients) of all the patients
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Table 1. Statistical calculations before and after discarding the extreme values.
Before discarding the extreme values

After discarding the extreme values

7964

6957

Mean (ng/mL)

17.32

16.00

SD

10.74

7.42

Median

14.62

14.43

Variance

115.44

55.10

Range

75.0

34.46

Minimum

4.0

5.47

Maximum

79

39.93

Interquartile range (IQR)

13.09

11.03

N

Table 2. Statistical calculations of sex and age data after discarding extreme values. 
Female

Male

18–30 years

31–40 years

41–50 years

51–60 years

61–70 years

5853 (84.1%)

1104 (15.9%)

889 (12.8%)

1253 (18%)

1871 (26.9%)

1824 (26.2%)

1120 (16.1%)

Mean (ng/mL)

15.17

20.39

16.76

15.79

15.70

16.29

15.82

SD

7.05

7.77

7.43

7.51

7.45

7.52

7.32

Median

13.62

20.0

15.70

14.0

14.0

14.64

14.16

Variance

49.79

60.44

55.28

52.60

55.58

56.67

53.70

Range

30.53

34.33

33.47

33.51

33.63

34.43

34.32

Minimum

5.47

5.60

5.53

5.49

5.49

5.50

5.47

Maximum

30.53

39.93

39.0

39.0

39.12

39.93

39.79

IQR

10.48

11.88

11.44

10.84

11.07

11.48

11.23

N (%)

Table 3. Statistical calculations of season data after discarding the extreme values. 
Winter

Spring

Summer

Autumn

851 (12.2%)

2323 (33.4%)

2442 (35.1%)

1341 (19.3%)

Mean (ng/mL)

13.38

13.89

17.60

18.43

SD

6.06

6.06

7.84

8.01

Median

12.11

12.54

16.48

17.65

Variance

36.72

36.71

61.59

64.20

Range

24.94

25.53

34.44

34.35

Minimum

5.51

5.47

5.49

5.5

Maximum

30.35

31.0

39.93

39.85

IQR

8.80

9.0

11.92

12.81

N
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Table 4. Determined reference values by indirect method.
95% reference values

Lower 90% CI

Upper 90% CI

6.43–30.0 ng/mL

6.26–6.6

29.83–30.17

Reference values for female patients

6.31–29.05 ng/mL

6.25–6.61

28.87–29.03

Reference values for male patients

8.65–34.86 ng/mL

8.2–9.1

34.41–35.31

Winter

6.18–26.31 ng/mL

6.03–6.33

25.65–26.97

Spring

6.18–25.65 ng/mL

6.03–6.33

20.08–26.29

Summer

6.73–32.04 ng/mL

6.56–6.90

31.24–32.84

Fall

7.19–32.45 ng/mL

7.01–7.37

31.64–33.26

Total reference values

Reference values for season

CI: Confidence interval.
studied; 49.54% (547 patients) of the male patients and
75.32% (4409 patients) of the female patients were vitamin
D-deficient. Rates of vitamin D deficiency were 84.84%
(722 patients) in winter, 81.27% (1888 patients) in spring,
63.63% (1554 patients) in summer, and 59.06% (792
patients) in fall.
4. Discussion
Serum 25(OH)vitD3 determination is a good indicator of
general vitamin D status. Vitamin D2 and vitamin D3 are
two important forms of vitamin D; however, the potency
and duration of activity of vitamin D2 are less than those
of vitamin D3. Vitamin D levels are generally evaluated by
the measurement of serum 25(OH)vitD3 concentration
(15). The measurement of 25(OH)vitD3 is important as
a clinical indicator of nutritional vitamin D deficiency.
When 25(OH)vitD3 levels are <20 ng/mL, 20–30 ng/
mL, and >30 ng/mL, it is accepted to indicate vitamin D
deficiency, vitamin D insufficiency, and normal vitamin D,
respectively (16–19). Though cut-off values are proposed
by some institutions to determine vitamin D deficiency
and insufficiency, clinical correlations for these cut-off
levels are not so evident (20). For this reason, we aimed
to determine the reference interval of the 25(OH)vitD3
test with the indirect method and explore its relation to
age, sex, and season by using the patient data of this test
obtained within approximately 4 years.
The use of the reference interval in evaluating
laboratory test results has indispensable importance. It is
essential for clinicians to decide the clinical diagnosis and
therapy. Additionally, the IFCC and CLSI propose that
every laboratory determine its own reference intervals.
For the selection of reference individuals that optimally
represent the reference population, the direct and indirect

methods are used. In the direct method, individuals are
sampled from the main population based on defined
criteria and in this method questionnaires prepared based
on these criteria are first completed, then laboratory
analyses are performed. At least 120 healthy subjects are
needed for each group, which is difficult to achieve. In
the indirect method, tests results are selected based on
certain rules from a database in which analysis results are
recorded regardless of individuals (2,3). When factors such
as application difficulties and expenses are considered, the
indirect method is more advantageous for laboratories in
determining their own reference intervals.
In the current study, we calculated the 95% 25(OH)
vitD3 reference interval within a 90% confidence interval.
The reference interval was determined to be notably lower
than the lower limit reference value that the manufacturing
company proposed (reference values based on health
status and population). We found significant differences
in group comparisons related to sex, and the reference
interval values were also different (Table 4). According
to these results, though the reference interval lower limit
values that we found were much lower than the cut-off
value proposed for vitamin D deficiency, it would be
accurate to determine the 25(OH)vitD3 reference interval
in relation to sex. In the present study, 25(OH)vitD3 levels
did not differ significantly between the subgroups of age.
In a study performed in the United States, the prevalence
of vitamin D deficiency was the lowest in patients who
were 1–8 years old, and it then increased to a considerable
degree until 30 years of age in men and until 18 years
of age in women. It did not change considerably in later
years (21). Group comparisons that we made in relation to
seasons showed significant differences. In both sexes and
in age subgroups, serum vitamin D concentrations were
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lower in winter, and these levels increased in summer and
fall. Bhattoa et al. determined the lowest level in winter
and the highest level in summer (22). In many studies,
vitamin D level was affected by factors including seasons,
geographic area, ethnicity, kidney diseases, malabsorption
syndromes, genetics, obesity, sex, age, inadequate sun
exposure, and regular use of sun-protective agents (23,24).
In this study, a large proportion of the patients were
determined to have 25(OH)vitD3 deficiency when the cutoff value was accepted as <20 ng/mL for the deficiency
of 25(OH)vitD3. Vitamin D deficiency was considerably
frequent in female patients. The rate of 25(OH)vitD3
deficiency was very high in winter, whereas it decreased
as fall was approaching. These results are in accordance
with those of studies performed in many countries, and
these studies determined that 25(OH)vitD3 deficiency
is commonly seen worldwide (25,26). Vitamin D
insufficiency/deficiency leads to calcium malabsorption,
secondary hyperparathyroidism, muscle weakness, and/
or osteoporosis or osteomalacia. In addition, low vitamin
D status was related to severe diabetes mellitus type 1,
cardiovascular diseases, some types of cancer, decreased
cognition, pregnancy complications, autoimmune
diseases, and the risk of allergies (27).

While sampling the patients, factors that may affect
vitamin D levels were excluded in our study; however, we
detected vitamin D deficiency in most of the patients. The
reference interval that we determined with the indirect
method from the 25(OH)vitD3 results of the hospital
information system was not completely compatible with
the healthy population. An evaluation of the reference
interval by using patient test results is a relatively simple
and inexpensive method. The disadvantages of this
method are a lack of compatibility of the results with the
healthy population defined by the IFCC and CLSI, and
insufficiency of preanalytical and analytical controls while
obtaining the results (2,3,5). This study must therefore be
performed in a healthy population as well. Our data can
be evaluated with the reference interval results obtained
from other regions of Turkey and may also contribute to
the determination of 25(OH)vitD3 reference intervals and
vitamin D levels in the Turkish population. Our study is
important for the comparison of the reference interval
proposed by the producing (manufacturing) company,
and also for the indication of vitamin D levels in the
population. It would also be accurate to use the direct
method in determining the reference interval of the
vitamin D test, and to compare the two results.
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